MENU
LRMR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Larimar Therapeutics (LRMR) Ownership - Who owns Larimar Therapeutics?
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform... Show more
Profile
Industry
N/A
Address
Three Bala Plaza East
Phone
+1 844 511-9056
Employees
42
Web
https://www.larimartx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
152.39M
P/E Ratio
N/A
Total Cash
203.71M
Projected Growth
N/A
Total Debt
5.36M
Revenue
N/A
Risk (Beta)
0.67
Dividend Yield
N/A
Total Cash/Share
3.18
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
LRMR
Capitalization
152M
P/E Ratio
N/A
Risk (Beta)
0.67
Dividend Yield
N/A
Total Cash
204M
Total Cash/Share
3.18
Total Debt
5.36M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
198M
P/B Ratio
0.84
Cash Flow
N/A
Earnings
-1.15
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
64K
Current Ratio
13.10
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-73.44M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-40.11
Shares Held By Institutions
271M
Shares Outstanding - Current
64M
Total Liabilities
20.6M
Total Volume MTD
N/A
Value
1
Gain YTD
-41.602
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical-stage biopharmaceutical company, which engages in the research and development of a therapeutic treatment for mitochondrial disorders and Friedreich's ataxia
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
Three Bala Plaza East
Phone
+1 844 511-9056
Employees
42
Web
https://www.larimartx.com